Mar 01, 2019 EBMT receives a regulatory qualification from the European Medicine Agency (EMA) on the use of its patient registry to support novel CAR T-cell therapies.
Feb 15, 2019 Position statement providing general information for patients and carers considering HSCT for severe autoimmune diseases